Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-020897
Filing Date
2025-03-05
Accepted
2025-03-05 16:30:52
Documents
5
Effectiveness Date
2025-03-05

Document Format Files

Seq Description Document Type Size
1 S-8 tm258093d1_s8.htm S-8 53283
2 EXHIBIT 5.1 tm258093d1_ex5-1.htm EX-5.1 6209
3 EXHIBIT 23.1 tm258093d1_ex23-1.htm EX-23.1 1561
4 EXHIBIT 23.2 tm258093d1_ex23-2.htm EX-23.2 2288
5 EX-FILING FEES tm258093d1_ex-filingfees.htm EX-FILING FEES 15129
  Complete submission text file 0001104659-25-020897.txt   79590
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285572 | Film No.: 25711694
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)